| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 744 | 10.608 | 13.717 | 18.952 | 31.075 | 46.975 | 45.233 |
| Total Income - EUR | - | - | - | 744 | 10.608 | 13.717 | 19.013 | 31.075 | 46.975 | 45.235 |
| Total Expenses - EUR | - | - | - | 15 | 4.699 | 3.488 | 4.640 | 4.649 | 10.340 | 12.214 |
| Gross Profit/Loss - EUR | - | - | - | 729 | 5.910 | 10.229 | 14.374 | 26.425 | 36.636 | 33.022 |
| Net Profit/Loss - EUR | - | - | - | 707 | 5.592 | 9.817 | 13.867 | 25.868 | 36.166 | 31.665 |
| Employees | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Yabadpal Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 26 | 26 | 667 | 498 | 346 | 191 | 37 |
| Current Assets | - | - | - | 772 | 11.261 | 24.357 | 41.038 | 70.725 | 66.202 | 98.610 |
| Inventories | - | - | - | 0 | 0 | 374 | 93 | 0 | 0 | 0 |
| Receivables | - | - | - | 744 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | 28 | 11.261 | 23.983 | 40.945 | 70.725 | 66.202 | 98.610 |
| Shareholders Funds | - | - | - | 750 | 6.327 | 16.024 | 29.535 | 25.917 | 62.004 | 93.322 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 49 | 4.960 | 8.999 | 12.001 | 45.154 | 4.389 | 5.326 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Yabadpal Med S.r.l.